The MDM2 Inhibitor Nutlins as an Innovative Therapeutic Tool for the Treatment of Haematological Malignancies

E-ISSN： 1873-4286|14|21|2100-2110

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.21, 2008-07, pp. : 2100-2110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MDM2 Non-Genotoxic Inhibitors as Innovative Therapeutic Approaches for the Treatment of Pediatric Malignancies

Current Medicinal Chemistry, Vol. 20, Iss. 17, 2013-06 ,pp. : 2226-2236

Bentham Science Publishers

Access to resources Recommend Favorite

Endocannabinoid System: A Promising Therapeutic Target for the Treatment of Haematological Malignancies?

Current Medicinal Chemistry, Vol. 23, Iss. 22, 2016-07 ,pp. : 2350-2362

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the treatment for haematological malignancies

By Piccaluga Pier Paolo Martinelli Giovanni Baccarani Michele

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 721-732

Informa Healthcare

Access to resources Recommend Favorite

IAPs as therapeutic targets in haematological malignancies

By Langemeijer SMC de Graaf AO Jansen JH

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 981-993

Informa Healthcare

Access to resources Recommend Favorite

Arsenic trioxide in the treatment of haematological malignancies

By Kwong Yok-Lam

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 589-597

Informa Healthcare

Access to resources Recommend Favorite